View by sections
Integrated drug treatment and HIV prevention, treatment and care services (IDNK29)
|No. and Title:||IDNK 29 - Integrated drug treatment and HOV prevention, treatment and care services|
|Status/Starting Date:||December 2009 - December 2011|
|Field:||Prevention, Treatment, and Reintegration, and Alternative Development, Treatment and rehabilitation of drug-dependent persons|
The main activities planned to be implemented in Indonesia both by public health institutions and by community based organizations in the area of prevention of transmission among injecting drug users and their partners are 1) outreach for education on harm reduction and risk reduction for sexual transmission for both injecting drug users and their regular sexual partners 2) needle and syringe programmes for injecting drug users 3) methadone maintenance therapy for people with opiate dependence (establishing new sites; revision of guidelines; and training of service providers and addiction counsellors) and 4) community drug dependence treatment as entry to harm reduction, HIV prevention, and VCT referrals.
The aim of this program is to promote policies that strike the right balance between the reduction of drug supply and demand, and incorporate science-based drug prevention and dependence treatment.
Humane and accessible treatment and care for more people with drug dependence and drug-related diseases (particularly HIV/AIDS) that will result in opportunities for rehabilitation and reintegration into society.
Essential services based on scientific evidence which provide a recovery-oriented continuum of care, matching the needs of dependent drug users in all social, motivational and clinical stages.
Integrated drug treatment and HOV prevention, treatment and care services
In July 2009 Indonesia started the implementation of the GFTAM funded program. One of the main priorities of the program is the provision of drug treatment services through methadone maintenance therapy to injecting drug users. Under this vast program in 12 most affected by the HIV/AIDS epidemic provinces, the Ministry of Health as the PR for methadone maintenance intervention and the National AIDS Commission as the PR for all other harm reduction interventions will develop methadone maintenance therapy for people with opiate dependence (establishing new sites; revision of guidelines; and training of service providers and addiction counsellors) and scale- up community drug dependence treatment as entry to harm reduction, HIV prevention, and VCT referrals.
UNODC is particularly well placed to provide technical support in the area of scaling-up methadone maintenance therapy for people with opiate dependence and expansion of community drug dependence treatment.
At the global level, recently a new initiative was launched under the leadership of UNODC and WHO: UNODC-WHO Joint Programme on Drug Dependence Treatment and Care.The collaboration includes governments, health professionals, non-governmental organizations (NGOs) and funding agencies committed to increasing the coverage of essential services for drug dependence treatment and care.
UNODC, a co-sponsor of the Joint United Nations Programme on HIV/AIDS (UNAIDS), is also the lead agency in the UNAIDS family for HIV and AIDS prevention and care among injecting drug users and in prison settings. The focus of the work of UNODC in these areas is to assist States in implementing large-scale and wide-ranging interventions to prevent HIV infections and in providing care and support to people living with HIV and AIDS.
Currently UNODC work in Indonesia is focused on assisting the Indonesian Government in the development of effective strategies and reviewing and adapting national HIV/AIDS policy and implementation plans and linking them to relevant policies, strategies such as those for increasing access to evidence-based interventions integrating HIV and drug treatment programs for IDUs.
Objective: More effective drug dependence treatment and HIV prevention services to clients. Increased access to quality and affordable drug dependence treatment services (particularly Opioid Agonists) thus contributing to reduce negative health and social consequences of drug use, particularly HIV transmission as it relates to injecting drug use.
Outcome 1: Enhanced national coordination mechanism established - strengthened national coordination mechanism for enabling quality and affordable drug dependence treatment services integrated with HIV prevention services.
Output 1.1: Support provided to strengthened the National coordination mechanism to promote integrated drug treatment (particularly Opioid Agonists) and HIV prevention, treatment and care services, and to reach an agreement on drug dependdence treatment coordination and decision making mehanism.
Output 1.2: Report produced on the state of drug dependence, associated HIV, treatment services and needs. Technical support provided to the national working group for conducting situation analysis on drug use and HIV, drug treatment services and related capacity building activities and dependence treatment services and needs in the 5 Indonesian provinces included in the project. Report produced and disseminated among the national stakeholders.
Outcome 2: Community based drug treatment and HIV prevention programmes established and sustained.
Output 2.1: National mechanism established for coordination of the training.
Output 2.2: Training materials (in particular Treatnet Training Package) on comprehensive evidence-based approaches adopted and translated into Bahasa Indonesia (based on the Treatnet module), and trainign providers trained.
Output 2.3: Training delivered and evaluated for at least 150 service providers and other relevant professionals (doctors, philologists, nurses, social workers and project staff like volunteers, former drug users) in applying basic pharmacological and psychosocial clinical approaches regarding substance abuse and HIV related conditions.
Output 2.4: Community-based drug dependence treatment/HIV prevention projects developed in at least five sites in Indonesia with the aim to establish high quality drug treatment and HIV prevention treatment and care services provided in an integrated manner that single point-of-care for drug users and will increase the access for both male and female IDU.
Outcome 3: Drug-users destigmatised and greater awareness amng the general population of drug dependence as a health condition requiring health responses
Increased understanding among the general population (particularly the families and media) of drug dependence as a health condition requiring health responses, and the need to decrease stigma to counteract misleading opinions about drug treatment and drug users.
Output 3.1: Advocacy strategy implemented to gain families support and ensure the necessary legal and institutional framework to expand quality HIV prevention and care through drug dependence treatment